Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.4.1 (
myosin ATPase
)
1,140
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effects of
Troponin T
(
TnT
) mutants R141W and DeltaK210, the only two currently known mutations in
TnT
that cause dilated cardiomyopathy(DCM) independent of familial hypertrophic cardiomyopathy (FHC), and
TnT
-K273E, a mutation that leads to a progression from FHC to DCM, were investigated. Studies on the Ca2+ sensitivity of force development in porcine cardiac fibers demonstrated that
TnT
-DeltaK210 caused a significant decrease in Ca2+ sensitivity, whereas the
TnT
-R141W did not result in any change in Ca2+ sensitivity when compared with human cardiac wild-type
TnT
(HCWTnT).
TnT
-DeltaK210 also caused a decrease in maximal force when compared with HCWTnT and
TnT
-R141W. In addition, the
TnT
-DeltaK210 mutant decreased maximal ATPase activity in the presence of Ca2+. However, the
TnT
-K273E mutation caused a significant increase in Ca2+ sensitivity but behaved similarly to HCWTnT in actomyosin activation assays. Inhibition of ATPase activity in reconstituted actin-activated
myosin ATPase
assays was similar for all three
TnT
mutants and HCWTnT. Additionally, circular dichroism studies suggest that the secondary structure of all three
TnT
mutants was similar to that of the HCWTnT. These results suggest that a rightward shift in Ca2+ sensitivity is not the only determinant for the phenotype of DCM.
...
PMID:Different functional properties of troponin T mutants that cause dilated cardiomyopathy. 1292 87